project id: TCGA-UVM; case submitter id: TCGA-VD-A8KM; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.5; age at index: 65; days to birth: -24047; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1948; age at diagnosis: 24047; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 200; days to sample procurement: 0; initial weight: 10.0; sample id: 6c2b6953-a382-4a96-a578-c6a50464bf75; sample submitter id: TCGA-VD-A8KM-01A; portion id: 7efa6629-4223-4a39-8c3e-569eddc2a7aa; portion submitter id: TCGA-VD-A8KM-01A-11; slide id: 1d881a73-fe65-4cc3-aa03-4f4bc168205a; slide submitter id: TCGA-VD-A8KM-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;